Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+642.5%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+642.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
409.3x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 6405.10% |
| 2024 | -107.98% |
| 2023 | 119.24% |
| 2022 | 15.65% |
| 2021 | -4.35% |
| 2020 | -120.87% |
| 2019 | 50.51% |
| 2018 | -46.98% |
| 2017 | -24.40% |
| 2016 | -62.68% |